
Human PsyMAP™ v 1.0
A 51-biomarker Multi-Analyte Profile (MAP) that can identify biomarker patterns associated with psychiatric disorders such as schizophrenia, major depressive disorder, and bipolar disorder. In serum samples, a percent probability score is provided to help differentiate subjects with schizophrenia from normal individuals using a proprietary algorithm. This PsyMAP score should be useful as part of inclusion/exclusion criteria when enrolling schizophrenia subjects for clinical trials. RBM’s PsyMAP™ is a novel tool that delivers a sensitive and specific service to aid in the research and development of therapeutics for psychiatric disorders.Sample Volume Requirements
Mouse over each antigen to view its definition

